Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.1298 |
June 30, 2019 | 0.1794 |
March 31, 2019 | 0.2568 |
December 31, 2018 | 0.3213 |
September 30, 2018 | 0.2558 |
June 30, 2018 | 0.202 |
March 31, 2018 | 0.1591 |
December 31, 2017 | 0.0278 |
Date | Value |
---|---|
September 30, 2017 | 0.0216 |
June 30, 2017 | 0.016 |
March 31, 2017 | 0.0165 |
December 31, 2016 | 0.0179 |
September 30, 2016 | 0.0191 |
June 30, 2016 | 0.0152 |
March 31, 2016 | 0.0152 |
December 31, 2015 | 0.0157 |
September 30, 2015 | 0.0142 |
June 30, 2015 | 0.0144 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.1794
Maximum
Jun 2019
0.0163
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Novavax Inc | -0.2344 |
aTyr Pharma Inc | -- |
Allogene Therapeutics Inc | 0.00 |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 91.83M |
Total Liabilities (Quarterly) | 34.02M |
Shareholders Equity (Quarterly) | 57.80M |
Current Ratio | 3.318 |